Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

LR HEALTH & BEAUTY SYSTEMS ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.3% 2.3%   Bankruptcy risk   15.4% 12.6% 14.4% 13.9% 14.1% 14.6% 17.0% 17.0%   Credit score (0-100)   14 20 15 15 15 13 10 10   Credit rating   BB BB BB BB BB BB BB BB   Credit limit (kDKK)   -0.0 -0.0 -0.0 -0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -232 -617 270 -79.6 -510 288 0.0 0.0   EBITDA   -1,442 -1,818 -1,380 -783 -1,336 -1,078 0.0 0.0   EBIT   -1,470 -1,936 -1,515 -922 -1,439 -1,084 0.0 0.0   Pre-tax profit (PTP)   -1,775.1 -1,954.7 -1,453.5 -914.8 -1,381.1 -1,102.5 0.0 0.0   Net earnings   -1,775.1 -1,954.7 -1,453.5 -914.8 -1,381.1 -1,102.5 0.0 0.0   Pre-tax profit without non-rec. items   -1,775 -1,955 -1,453 -915 -1,381 -1,102 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   452 338 255 116 13.9 4.9 0.0 0.0   Shareholders equity total   -16,464 -18,419 -19,872 -20,787 -22,168 -23,270 -23,395 -23,395   Interest-bearing liabilities   17,107 19,031 20,477 21,268 22,848 23,639 23,395 23,395   Balance sheet total (assets)   1,655 1,571 1,790 1,185 1,419 1,227 0.0 0.0   Net Debt   16,454 18,633 19,930 20,695 22,094 22,903 23,395 23,395     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -232 -617 270 -79.6 -510 288 0.0 0.0   Gross profit growth   77.1% -165.5% 0.0% 0.0% -541.1% 0.0% -100.0% 0.0%   Employees   2 3 3 2 2 3 0 0   Employee growth %   0.0% 50.0% 0.0% -33.3% 0.0% 50.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,655 1,571 1,790 1,185 1,419 1,227 0 0   Balance sheet change%   22.8% -5.0% 13.9% -33.8% 19.8% -13.5% -100.0% 0.0%   Added value   -1,441.7 -1,818.0 -1,379.8 -782.8 -1,299.9 -1,078.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   378 -233 -218 -278 -205 -15 -5 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -3.0 -4.0 -5.0 -5.0 -5.0 -5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   632.3% 313.6% -561.3% 1,158.0% 281.9% -376.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -8.6% -10.2% -6.7% -3.9% -6.0% -4.5% 0.0% 0.0%   ROI %   -9.3% -10.7% -7.0% -4.1% -6.2% -4.6% 0.0% 0.0%   ROE %   -118.3% -121.2% -86.5% -61.5% -106.1% -83.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -90.9% -92.2% -91.7% -94.7% -94.3% -95.2% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -1,141.2% -1,024.9% -1,444.4% -2,643.7% -1,653.1% -2,124.0% 0.0% 0.0%   Gearing %   -103.9% -103.3% -103.0% -102.3% -103.1% -101.6% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.9% 0.1% 0.3% 0.3% 0.0% 0.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.1 1.1 1.2 1.3 1.9 1.4 0.0 0.0   Current Ratio   1.1 1.1 1.2 1.3 1.7 1.3 0.0 0.0   Cash and cash equivalent   653.4 398.9 546.1 572.9 754.1 736.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   100.6 113.3 187.3 202.5 489.0 291.4 -11,697.7 -11,697.7   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -721 -606 -460 -391 -650 -359 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -721 -606 -460 -391 -668 -359 0 0   EBIT / employee   -735 -645 -505 -461 -719 -361 0 0   Net earnings / employee   -888 -652 -484 -457 -691 -367 0 0